Baird Capital invests in Freemarket

Baird Capital has completed a growth capital investment in Freemarket. The investment supports Freemarket’s continuing fast growth and international expansion, as well as providing a partial cash-out to existing shareholders.

Founded in 1989, Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors globally. Since 1989, the firm has raised and managed more than US$4 billion and invested in over 335 portfolio companies.

Founded in 2011, Freemarket provides its customers with reliable and efficient B2B cross-border payments through its proprietary technology platform. Freemarket’s global banking network and innovative technology platform enables customers to send payments/funds efficiently to over 100 countries in 140 currencies, removing cross-border payment complexities, improving transparency and increasing efficiency.

Oaklins Cavendish, based in the UK, acted as buy-side advisor to Baird Capital on a growth capital investment from its global private equity team, into Freemarket.

Service

M&A buy-side

Parties

“We are delighted to have completed this investment and look forward to partnering with the Freemarket management team as they seek to capitalize on the market opportunity before them. It has been a pleasure to work with the team at Oaklins Cavendish on this transaction – we valued the support and expert sector knowledge they provided throughout the process.”

Michael Holgate

Partner, Baird Capital

Talk to the deal team

Ben Goldring

Partner

London, United Kingdom
Oaklins Cavendish

View profile Get in touch

Tom Holland-Hibbert

Senior Associate

London, United Kingdom
Oaklins Cavendish

View profile Get in touch

Related deals

Den Berk Délice accelerates growth through strategic partnership

Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more

Xiel Limited has been acquired by MIS Healthcare

Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more